The MHRA has authorised nipocalimab for generalised myasthenia gravis in adults and adolescents aged 12 and over, based on evidence from two clinical studies.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/mhra-approves-nipocalimab-myasthenia-gravis-2026a1000jgd?src=rss
Author :
Publish date : 2026-06-10 12:35:00
Copyright for syndicated content belongs to the linked Source.
